Little-known compound in aged garlic could be key to fighting age-related muscle decline
By isabelle // 2026-06-08
Copy
 
  • S-1-propenyl-L-cysteine in aged garlic extract activates a previously unknown fat-to-brain-to-muscle pathway for muscle protection.
  • This compound improved muscle strength, grip strength, and frailty scores in aged mice without increasing muscle size.
  • A small human trial showed the same biological signal after a single dose of 25 milligrams of S1PC.
  • The pathway stimulates NAD+ production by targeting the hypothalamus through eNAMPT protein secreted from fat tissue.
  • Further research is needed to confirm long-term functional gains in aging adults from this compound.
A compound hiding in aged garlic extract is doing something researchers didn't expect: it is starting a conversation between your fat tissue and your brain, and that conversation may help protect your muscle function as you age. Scientists from the Institute for Research on Productive Aging in Tokyo and Wakunaga Pharmaceutical Co. published findings in Cell Metabolism identifying S-1-propenyl-L-cysteine, or S1PC, as a bioactive compound in aged garlic extract that activates a previously unknown biological pathway. In aged mice, the compound improved muscle strength, grip strength, and lowered frailty scores. In a small human trial, it triggered the same biological signal. The question now is whether that signal translates into real-world functional gains for aging adults.

A relay race through the body

The researchers discovered that S1PC stimulates the LKB1-SIRT1 pathway in white adipose tissue. That activation increases secretion of eNAMPT, a protein that helps maintain NAD+ levels throughout the body. NAD+ is essential for mitochondrial function, DNA repair, and cellular energy production, and it declines with age. Here is the surprising part. Instead of traveling directly to skeletal muscle, eNAMPT targets the hypothalamus, a region of the brain that regulates metabolism and aging. The brain then communicates with skeletal muscle. In the study, researchers summarized this as a pathway running from the garlic compound to fat tissue, then to the brain, and finally to muscle. As the authors wrote, "eNAMPT secreted from WAT specifically targets the hypothalamus, but not skeletal muscle." This inter-organ communication represents what the researchers called a previously unidentified effect of the compound.

What the mice showed

After eight months of treatment, aged mice given S1PC showed stronger muscle force, better grip strength, and lower frailty scores compared to untreated mice. Notably, muscle size did not increase, suggesting the benefit came from improved muscle quality and function rather than growth. The mice also showed higher levels of proteins involved in energy production within muscle tissue. That pointed to improved metabolic health as a possible contributor. In a separate finding, combining S1PC with nicotinamide mononucleotide further enhanced eNAMPT secretion in aged mice. The researchers noted that testing the same combination in humans "will also be very interesting."

The human signal, for now

The human portion of the study included 40 healthy adults ages 20 to 49. Participants who maintained healthy body weight and body-fat levels experienced a rise in circulating eNAMPT after taking a 25-milligram tablet of S1PC. However, the study tested only a single acute dose. It did not measure muscle strength, mobility, or long-term aging outcomes. As the researchers acknowledged, it remains too early to know whether the muscle benefits seen in mice will translate to people. Dr. Shin-ichiro Imai, chairman of IRPA, stated, "Further research is needed to determine improvements in muscle function in humans and to evaluate the long-term effects of S1PC." Wakunaga of America President Ryuichi Sakamoto emphasized the potential impact. "These observations could be a game changer for millions of American seniors, particularly since research consistently links sarcopenia to increased all-cause and cause-specific mortality," he said. "Many see muscle retention as the currency of aging."

The bigger picture for healthy aging

The study arrives as aging populations drive demand for evidence-based nutraceuticals. McKinsey and Company's 2025 Future of Wellness survey found that up to 60 percent of consumers across markets report healthy aging as a top priority. The researchers positioned S1PC alongside other compounds studied for NAD+ biology, including NMN and nicotinamide riboside. They noted that "developing evidence-based anti-aging interventions is now becoming an urgent goal to deal with worldwide populational aging." Dr. Kiyoshi Yoshioka, one of the first authors, shared a personal motivation. "During my clinical experience as a physical therapist, I was often frustrated to see older adults lose physical function and vitality simply because they had no specific disease requiring medical treatment. This gap in proactive care has driven my research." For now, the best strategies for muscle resilience remain familiar. Resistance training, maintaining healthy body composition, and prioritizing metabolic health form the foundation. But this garlic-derived compound has opened a new door. If future human studies confirm the effect, the humble aged garlic bulb may hold more power than anyone guessed. Sources for this article include: MindBodyGreen.com NutraIngredients.com SciTechDaily.com
Copy